A new approach examines how individual cells respond to drugs, aiming to identify risks earlier in development.
Updated
April 15, 2026 6:01 PM
Close up of a capsule blister pack. PHOTO: UNSPLASH
DeepCyte, a startup in the drug development space, is focusing on a long-standing problem: why drugs that appear safe in early testing still fail in clinical trials or are withdrawn later due to toxicity. DeepCyte has launched with US$1.5 million in seed funding to build tools that detect and explain the harmful effects of drugs at much earlier stages.
The startup’s approach focuses on how individual cells respond to a drug. Instead of analysing cells in bulk, it studies them one by one. This helps capture differences in how cells react, which are often missed in traditional testing methods.
Drug toxicity remains one of the main reasons for failure in drug development. Methods such as animal testing and bulk cell analysis do not always reflect how human cells behave. This gap has pushed the industry to look for more reliable and human-relevant ways to test drug safety.
DeepCyte combines cell-level data with artificial intelligence. Its platform, MetaCore, studies what is happening inside individual cells by capturing detailed molecular information. This data is used to build large datasets that can train AI models.
Additionally, the company has developed an AI system called DeeImmuno. It is designed to predict whether a drug could be toxic and identify the biological reasons behind it. In internal testing on 100 drugs, the system identified different types of toxicity and their underlying mechanisms with a reported accuracy of 94 percent.
The focus on explaining why a drug is toxic, not just whether it is, reflects a broader shift in the industry. Regulators such as the U.S. Food and Drug Administration and the European Medicines Agency have been encouraging methods that rely more on human cell data and clearer biological evidence. The seed funding will be used to develop and scale these tools. The company aims to help drug developers make earlier decisions, which could reduce costly failures in later stages. Whether tools like this become widely used will depend on how they perform in real-world settings. For now, DeepCyte’s approach highlights a growing effort to make drug testing more precise by focusing on how drugs affect cells at the most detailed level.
Keep Reading
A wearable ring, conversational AI and US$23M in funding. Sandbar wants to rethink how we interact with technology
Updated
April 1, 2026 8:55 AM
Sandbar's Stream ring. PHOTO: SANDBAR
Sandbar, a New York–based interface startup, has raised US$23 million in Series A funding to develop a wearable device that lets people interact with artificial intelligence via voice rather than screens.
Adjacent and Kindred Ventures led the round; both venture firms focused on early-stage technology startups. The investment brings Sandbar’s total funding to us$36 million. Earlier backing included a US$10 million seed round led by True Ventures, a venture capital firm, as well as a US$3 million pre-seed round supported by Upfront Ventures, a venture firm and Betaworks, a startup studio and investment firm.
Sandbar was founded by Mina Fahmi and Kirak Hong, who previously worked together at CTRL-labs, a neural interface startup acquired by Meta in 2019. Their earlier work explored how computers could respond more directly to human intent — an idea that continues to shape Sandbar’s approach to AI interfaces.
The new funding will help the company expand its team across machine learning, interaction design and software engineering as it prepares to launch its first product. That product, called Stream, combines a wearable ring with a conversational AI interface. The system allows users to speak to an AI assistant without unlocking a phone or opening an app.
The concept is simple. Instead of typing into a screen, users press a button on the ring and talk. The system can capture notes, organize ideas, retrieve information from the web or trigger actions through connected applications.
The ring includes a microphone, a touchpad and subtle haptic feedback. These elements allow the device to respond through gentle vibrations rather than visual alerts. According to the company, the ring only listens when the user presses the button — a design meant to address common concerns around always-on microphones.
That design reflects a larger shift Sandbar believes is underway. As AI assistants become more capable, many startups are experimenting with new ways to interact with them. The focus is moving away from screens and keyboards toward interfaces that feel more natural and immediate.
Stream uses multiple AI models working together to process requests, search the web and structure information in real time. The company says users remain in control of their data and can choose whether to share information with other apps.
Sandbar is also developing a feature called Inner Voice, which responds using a voice customized to the user. The feature will debut during a closed beta planned for this spring, giving the company time to refine how the software behaves in everyday use.
The startup currently employs a team of 15 people. Many have worked on well-known consumer devices including the iPhone, Fitbit, Kindle and Vision Pro. Recent hires include Sam Bowen, formerly of Amazon and Fitbit, who joined as vice president of hardware and Brooke Travis, previously at Equinox, Dior and Gap, who now leads marketing.
Sandbar plans to begin shipping Stream in summer 2026 after completing early testing. As artificial intelligence tools become more integrated into daily life, the company is betting that the next shift in computing will not come from another app — but from new ways for people to interact with AI itself.